Friday, 21 March 2025
  
Login

Australia's most trusted
source of pharma news

Friday, 21 March 2025
News

CEO's half-a-billion-dollar payday

Posted 17 March 2025 PM

In a stroke of extraordinary good luck, BioNTech CEO, Ugur Sahin, collected close to half a billion dollars in 2024, the reward of a large share option deal signed three months before a monster windfall for the company.

The option was awarded in September 2019 before anyone had heard of COVID-19 and three months before the virus would emerge in China and six months before the World Health Organisation declared a pandemic.

To see the whole article, please login

Popular

Aussie pharma Mum on having it all
Why young hot shots are quitting
Back on board after LinkedIn fiasco
Butler brands PBS 'non-negotiable'
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (31)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (1)

Other (18)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2025 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home